Topical Pain Relief Market Increase in the Demand for Specific Formulations Presents Opportunities

Topical pain relief industry generated $8.86 billion in 2019, and is expected to reach $12.21 billion by 2027, witnessing a CAGR of 5.2% from 2020 to 2027.

PORTLAND, OREGON, UNITED STATES, January 11, 2022 /EINPresswire.com/ -- Rise in prevalence of arthritis, surge in demand for topical pain relief products by sportsperson, and few side effects caused by these products drive the growth of the global topical pain relief market. However, skin irritation caused by the products and unpleasant odor hinder the market growth. On the other hand, emergence of online pharmacy and opportunities in emerging countries present new opportunities in the coming years.

๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ :

โ€ข Advacare Pharma
โ€ข Glaxosmithkline Plc (GSK)
โ€ข Johnson & Johnson
โ€ข Nestlรฉ S.A.
โ€ข Novartis AG
โ€ข Pfizer Inc.
โ€ข Reckitt Benckiser Group Plc.
โ€ข Sanofi
โ€ข Sun Pharmaceutical Industries Ltd.
โ€ข Topical Biomedics, Inc.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/4663

๐—–๐—ผ๐˜ƒ๐—ถ๐—ฑ-๐Ÿญ๐Ÿต ๐—ฆ๐—ฐ๐—ฒ๐—ป๐—ฎ๐—ฟ๐—ถ๐—ผ:

โ€ข Owing to the lockdown imposed by governments of many countries, many clinics and pain relief services were closed down to curb the spread of Covid-19. During the post-lockdown, the clinics are expected to experience slow increase in the number of patients.
โ€ข In addition, most of the chronic pain facilities were considered non-urgent to shift focus on treating coronavirus-infected patients. Both outpatient and selected interventional procedures were restricted or stopped completely to reduce the risk of the spread.

๐…๐จ๐ซ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/4663

Based on therapeutic class, the non-opioids segment accounted for the highest market share in 2019, contributing to nearly three-fourths of the global topical pain relief market, and is expected to maintain its leadership status throughout the forecast period. Moreover, this segment is estimated to manifest the fastest CAGR of 5.5% from 2020 to 2027. This is attributed to its preferable use over opioid drugs for treatment of mild to moderate pain, lesser side effects as compared to opioids, and no room for substance abuse. The research also analyzes the opioids segment.

๐—š๐—ฒ๐˜ ๐——๐—ฒ๐˜๐—ฎ๐—ถ๐—น๐—ฒ๐—ฑ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/topical-pain-relief-market

๐†๐ž๐ญ ๐”๐ฉ ๐“๐จ 25% ๐ƒ๐ข๐ฌ๐œ๐จ๐ฎ๐ง๐ญ ๐จ๐ง ๐„๐ฏ๐ž๐ซ๐ฒ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ, ๐“๐ข๐ฅ๐ฅ ๐ญ๐ก๐ž ๐ƒ๐š๐ญ๐ž 15๐ญ๐ก ๐จ๐Ÿ ๐‰๐š๐ง๐ฎ๐š๐ซ๐ฒ 2022.

๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

Pain Management Devices Market

Veterinary Pain Management Market

๐€๐•๐„๐๐”๐„- ๐€ ๐’๐ฎ๐›๐ฌ๐œ๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง-๐๐š๐ฌ๐ž๐ ๐‹๐ข๐›๐ซ๐š๐ซ๐ฒ (๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐จ๐ง-๐๐ž๐ฆ๐š๐ง๐, ๐ฌ๐ฎ๐›๐ฌ๐œ๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง-๐›๐š๐ฌ๐ž๐ ๐ฉ๐ซ๐ข๐œ๐ข๐ง๐  ๐ฆ๐จ๐๐ž๐ฅ) ๐Ž๐Ÿ๐Ÿ๐ž๐ซ๐ž๐ ๐›๐ฒ ๐€๐ฅ๐ฅ๐ข๐ž๐ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

๐†๐ž๐ญ ๐š๐ง ๐š๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐จ ๐ญ๐ก๐ž ๐ฅ๐ข๐›๐ซ๐š๐ซ๐ฒ ๐จ๐Ÿ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐š๐ญ ๐š๐ง๐ฒ ๐ญ๐ข๐ฆ๐ž ๐Ÿ๐ซ๐จ๐ฆ ๐š๐ง๐ฒ ๐๐ž๐ฏ๐ข๐œ๐ž ๐š๐ง๐ ๐š๐ง๐ฒ๐ฐ๐ก๐ž๐ซ๐ž. ๐…๐จ๐ซ ๐ฆ๐จ๐ซ๐ž ๐๐ž๐ญ๐š๐ข๐ฅ๐ฌ, ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค: https://www.alliedmarketresearch.com/library-access

๐€๐›๐จ๐ฎ๐ญ ๐€๐ฅ๐ฅ๐ข๐ž๐ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.